Syneos Health, Inc. - (SYNH) News

Syneos Health, Inc. - (SYNH)

Today's Latest Price: $50.42 USD

1.48 (-2.85%)

Updated Sep 24 10:44am

Add SYNH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

Filter SYNH News Items

SYNH News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest SYNH News From Around the Web

Below are the latest news stories about Syneos Health Inc that investors may wish to consider to help them evaluate SYNH as an investment opportunity.

Hedge Funds Have Never Been This Bullish On Syneos Health, Inc. (SYNH)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress. […]

Yahoo | September 16, 2020

Syneos Health Announces Pricing of Secondary Offering of Common Stock

MORRISVILLE, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced the pricing of the previously announced underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of an aggregate of 7,000,000 shares of the Company’s common stock (the “Offering”) at a price to the public of $59.75 per share. Syneos Health is not selling and will not receive any proceeds from the proposed sale of the shares by the selling stockholders in this Offering. The Offering is expected to close on September 17, 2020, subject...

Yahoo | September 16, 2020

Thomas H. Lee and Advent offload Syneos health shares

Syneos Health (SYNH) has commenced an underwritten secondary offering by Thomas H. Lee Partners and Advent of 7M common sharesSyneos Health is not selling any shares and will not receive any proceeds.The Company has agreed to repurchase from the underwriters ~$30M common shares....

Seeking Alpha | September 15, 2020

Syneos Health Announces Secondary Offering of Common Stock

MORRISVILLE, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of 7,000,000 shares of the Company’s common stock (the “Offering”) pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). Syneos Health is not selling any shares and will not receive any proceeds from the sale of the shares by the selling stockholders in the Offering. The Company has agreed to repurchas...

Yahoo | September 15, 2020

Syneos Health (SYNH) Down 8.2% Since Last Earnings Report: Can It Rebound?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 5, 2020

Syneos Health to Present at the Baird 2020 Global Healthcare Conference

MORRISVILLE, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at the Baird 2020 Global Healthcare conference on September 9, 2020, at 8:30 a.m. ET. A live webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.About Syneos Health Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization....

Yahoo | September 2, 2020

Syneos Health-Idorsia Collaborate to Launch Daridorexant in US

Syneos Health (SYNH) inks deal with Idorsia to commercialize the treatment for insomnia in the United States.

Yahoo | September 1, 2020

Impressive CROs well set for stronger 2021 after COVID 'whipsaw,' Baird says

Hunting for values among healthcare's contract research organizations, Baird is pleased to find that the pandemic trough has been "much shallower than anticipated" - with near-term challenges "nowhere near as extraordinary as originally feared." That points to solid crisis management that has allowed investors to absorb resilient bookings and start...

Seeking Alpha | August 20, 2020

Impressive CROs well set for stronger 2021 after COVID-19 'whipsaw,' Baird says

Hunting for values among healthcare's contract research organizations, Baird is pleased to find that the pandemic trough has been "much shallower than anticipated" - with near-term challenges "nowhere near as extraordinary as originally feared." That points to solid crisis management that has allowed investors to absorb resilient bookings and start...

Seeking Alpha | August 20, 2020

Syneos Health, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Syneos Health, Inc. in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | August 7, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.572 seconds.